Ireland - English - HPRA (Health Products Regulatory Authority)

mylan ire healthcare limited - verapamil hydrochloride - film-coated tablet - 120 milligram(s) - phenylalkylamine derivatives; verapamil - selective calcium channel blockers with direct cardiac effects, phenylalkylamine - prophylaxis and/or treatment of:-
angina pectoris, including prinzmetal’s angina (coronary spasm, vasospastic angina).
supraventricular tachycardias such as paroxysmal supraventricular tachycardia, atrial fibrillation/flutter with rapid ventricular response (except in wpw syndrome, see “contraindications”).
mild to moderate essential hypertension

Ireland - English - HPRA (Health Products Regulatory Authority)

mylan ire healthcare limited - verapamil hydrochloride - solution for injection/infusion - 2.5 milligram(s)/millilitre - phenylalkylamine derivatives; verapamil - selective calcium channel blockers with direct cardiac effects, phenylalkylamine - for the treatment of : tachycardias, such as paroxysmal supraventricular tachycardia, atrial fibrillation/flutter with tachyarrhythmia (except in wpw syndrome, see section 4.3, contra-indications), supraventricular extrasystoles, ventricular extrasystoles if due to myocardial ischaemia. severe angina not responsive to oral therapy. severe hypertension and hypertensive crisis.

Ireland - English - HPRA (Health Products Regulatory Authority)

mylan ire healthcare limited - verapamil hydrochloride - prolonged-release tablet - 240 milligram(s) - phenylalkylamine derivatives; verapamil - selective calcium channel blockers with direct cardiac effects, phenylalkylamine - mild to moderate hypertension and coronary heart disease, i.e. prophylaxis of myocardial ischaemia, angina pectoris.

Ireland - English - HPRA (Health Products Regulatory Authority)

mylan ire healthcare limited - verapamil hydrochloride - film-coated tablet - 40 milligram(s) - phenylalkylamine derivatives; verapamil - selective calcium channel blockers with direct cardiac effects, phenylalkylamine - prophylaxis and/or treatment of: angina pectoris, including prinzmetal’s angina (coronary spasm, vasospastic angina):; supraventricular tachycardias such as paroxysmal supraventricular tachycardia, atrial fibrillation/flutter with rapid ventricular response (except in wpw syndrome, see “contra-indications”); mild to moderate essential hypertension.

Ireland - English - HPRA (Health Products Regulatory Authority)

mylan ire healthcare limited - verapamil hydrochloride - film-coated tablet - 80 milligram(s) - phenylalkylamine derivatives; verapamil

Malta - English - Medicines Authority

viatris healthcare limited damastown industrial park, mulhuddart, dublin 15, dublin , ireland - solution for injection/infusion - verapamil hydrochloride 2.5 mg - calcium channel blockers

Malta - English - Medicines Authority

viatris healthcare limited damastown industrial park, mulhuddart, dublin 15, dublin , ireland - prolonged-release tablet - verapamil hydrochloride 240 mg - calcium channel blockers

Ireland - English - HPRA (Health Products Regulatory Authority)

wilcox laboratories limited - digitoxin -

Ireland - English - HPRA (Health Products Regulatory Authority)

wilcox laboratories limited - digitoxin - tablets

Ireland - English - HPRA (Health Products Regulatory Authority)

wilcox laboratories limited - digitoxin - tablets - 0.1 milligram